TGF-β Signaling Pathways in the Development of Diabetic Retinopathy
International Journal of Molecular Sciences · 06.03.2024 · 25 (5) · 3052
DOI: 10.3390/ijms25053052 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.03.2024. Verfasst von Andrew Callan und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Diabetes Mellitus. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDA NIH HHS, NEI NIH HHS.
Abstract (Originalsprache)
Diabetic retinopathy (DR), a prevalent complication of diabetes mellitus affecting a significant portion of the global population, has long been viewed primarily as a microvascular disorder. However, emerging evidence suggests that it should be redefined as a neurovascular disease with multifaceted pathogenesis rooted in oxidative stress and advanced glycation end products. The transforming growth factor-β (TGF-β) signaling family has emerged as a major contributor to DR pathogenesis due to its pivotal role in retinal vascular homeostasis, endothelial cell barrier function, and pericyte differentiation. However, the precise roles of TGF-β signaling in DR remain incompletely understood, with conflicting reports on its impact in different stages of the disease. Additionally, the BMP subfamily within the TGF-β superfamily introduces further complexity, with BMPs exhibiting both pro- and anti-angiogenic properties. Furthermore, TGF-β signaling extends beyond the vascular realm, encompassing immune regulation, neuronal survival, and maintenance. The intricate interactions between TGF-β and reactive oxygen species (ROS), non-coding RNAs, and inflammatory mediators have been implicated in the pathogenesis of DR. This review delves into the complex web of signaling pathways orchestrated by the TGF-β superfamily and their involvement in DR. A comprehensive understanding of these pathways may hold the key to developing targeted therapies to halt or mitigate the progression of DR and its devastating consequences.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, The University of Texas Rio Grande Valley, Edinburg, TX 78539, USA.
Förderung
- NCI NIH HHS
- NIDA NIH HHS
- NEI NIH HHS
- NIH
- HCA Healthcare
Zitieren
APA
Callan, A., Jha, S., Valdez, L., Baldado, L., & Tsin, A. (2024). TGF-β Signaling Pathways in the Development of Diabetic Retinopathy. International Journal of Molecular Sciences, 25(5), 3052. https://doi.org/10.3390/ijms25053052
Vancouver
Callan A, Jha S, Valdez L, Baldado L, Tsin A. TGF-β Signaling Pathways in the Development of Diabetic Retinopathy. International Journal of Molecular Sciences. 2024;25(5):3052. doi:10.3390/ijms25053052
BibTeX
@article{Callan2024,
author = {Callan, Andrew and Jha, Sonal and Valdez, Laura and Baldado, Lois and Tsin, Andrew},
title = {TGF-β Signaling Pathways in the Development of Diabetic Retinopathy},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {5},
pages = {3052},
doi = {10.3390/ijms25053052}
}
EUVIMED